Viridian Therapeutics, Inc.VRDNNASDAQ
Loading
Gross profit as a percentage of revenue
3Y CAGR
-0.2%/yr
Annual compound
Percentile
P62
Within normal range
vs 3Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | 99.55% | -0.5% |
| 2024 | 100.00% | 0.0% |
| 2023 | 100.00% | 0.0% |
| 2022 | 100.00% | 0.0% |
| 2021 | 100.00% | +103.9% |
| 2020 | -2595.62% | -2695.6% |
| 2019 | 100.00% | +138.1% |
| 2018 | -262.76% | +32.7% |
| 2017 | -390.21% | -1750.3% |
| 2016 | 23.64% | - |